We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$45.2B
AUM Growth
+$7.19B
Cap. Flow
+$5.18B
Cap. Flow %
11.47%
Top 10 Hldgs %
25.47%
Holding
2,621
New
399
Increased
1,662
Reduced
366
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 16.22%
2 Financials 7.54%
3 Healthcare 7.44%
4 Consumer Staples 5.34%
5 Consumer Discretionary 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
876
Globus Medical
GMED
$10.9B
$3.27M 0.01%
45,750
+9,404
+26% +$664K
XLP icon
877
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$3.24M 0.01%
39,076
+2,265
+6% +$182K
ITCI
878
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.23M 0.01%
44,107
+17,027
+63% +$1.28M
FMC icon
879
FMC
FMC
$1.37B
$3.22M 0.01%
48,888
+25,122
+106% +$1.54M
DVA icon
880
DaVita
DVA
$15.4B
$3.22M 0.01%
19,644
+4,165
+27% +$615K
EVRG icon
881
Evergy
EVRG
$19.7B
$3.22M 0.01%
51,912
+12,657
+32% +$736K
NMRA icon
882
Neumora Therapeutics
NMRA
$311M
$3.21M 0.01%
+242,900
New +$2.83M
SMB icon
883
VanEck Short Muni ETF
SMB
$312M
$3.21M 0.01%
185,410
+35,785
+24% +$614K
TTC icon
884
Toro Company
TTC
$9.08B
$3.2M 0.01%
36,927
+12,157
+49% +$1.09M
UTHR icon
885
United Therapeutics
UTHR
$26.1B
$3.18M 0.01%
8,886
+4,005
+82% +$1.35M
VMC icon
886
Vulcan Materials
VMC
$37.4B
$3.18M 0.01%
12,698
+2,354
+23% +$585K
NVT icon
887
nVent Electric
NVT
$22.9B
$3.18M 0.01%
45,248
+26,832
+146% +$1.85M
ALB icon
888
Albemarle
ALB
$13.3B
$3.17M 0.01%
33,509
+6,607
+25% +$587K
AOS icon
889
A.O. Smith
AOS
$8.82B
$3.17M 0.01%
35,234
+13,648
+63% +$1.13M
IWS icon
890
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$3.16M 0.01%
23,896
+10,350
+76% +$1.31M
DTE icon
891
DTE Energy
DTE
$30.4B
$3.15M 0.01%
24,540
-54,074
-69% -$6.52M
PNR icon
892
Pentair
PNR
$10.8B
$3.14M 0.01%
32,160
+18,196
+130% +$1.56M
ITA icon
893
iShares US Aerospace & Defense ETF
ITA
$14.5B
$3.14M 0.01%
21,014
-249
-1% -$35.1K
ILMN icon
894
Illumina
ILMN
$29.2B
$3.14M 0.01%
24,076
+15,231
+172% +$1.88M
NEM icon
895
Newmont
NEM
$96.4B
$3.13M 0.01%
58,535
+19,321
+49% +$960K
CSL icon
896
Carlisle Companies
CSL
$14.1B
$3.13M 0.01%
6,951
+2,285
+49% +$945K
PAA icon
897
Plains All American Pipeline
PAA
$17.2B
$3.12M 0.01%
179,847
+163,049
+971% +$2.92M
HLT icon
898
Hilton Worldwide
HLT
$72.6B
$3.11M 0.01%
13,505
+3,773
+39% +$817K
GTES icon
899
Gates Industrial Corporation Ltd.
GTES
$6.69B
$3.1M 0.01%
176,382
+23,175
+15% +$395K
DORM icon
900
Dorman Products
DORM
$4.28B
$3.09M 0.01%
27,300
+9,201
+51% +$968K

Similar funds

Cerity Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Cerity Partners held 2,621 positions worth $45.2B, up 19% from $38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cerity Partners deployed $5.18B of net new capital in Q3 2024, opening 399 new positions and adding to 1,662 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,234,812 shares worth $1.18B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $64M trimmed.

  • Cerity Partners's largest Q3 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,234,812 shares worth $1.18B.
  • Cerity Partners added most to Apple in Q3 2024, an estimated $250M increase.
  • Cerity Partners's biggest Q3 2024 reduction was Vanguard Total Stock Market ETF, cutting an estimated $64M.
  • Cerity Partners fully exited AssetMark Financial Holdings, Inc. in Q3 2024, selling an estimated $20.9M.
  • Cerity Partners's ten largest holdings make up 25% of its $45.2B portfolio in Q3 2024.
  • Cerity Partners opened 399 new positions and closed 95 in Q3 2024.
  • Cerity Partners's portfolio value rose 19% quarter-over-quarter to $45.2B.

Based on Cerity Partners's 13F filing for Q3 2024, filed 12 Nov 2024.